BREAKING NEWS: Wall Street Journal article puts spotlight on the potential of new anticoagulants taking fresh aim at one of cardiology’s toughest challenges.

Biotech Nation: Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics

Blood clots of any sort are dangerous. So dangerous in fact, that 1 in 4 people die from blood clots – independent of medical condition, medicines they take, or medical procedures they undergo. Dr. Daniel Bloomfield, the Chief Medical Officer of Anthos Therapeutics, describes their approach to preventing bleeding while avoiding blood clotting.

Listen to Audio